S Moosburner1, P V Ritschl1,2, L Wiering1, J M G V Gassner1, R Öllinger1, J Pratschke1, I M Sauer1, N Raschzok3,4. 1. Chirurgische Klinik, Campus Charité Mitte und Campus Virchow-Klinikum, Charité - Universitätsmedizin Berlin, Augustenburger Platz 1, 13353, Berlin, Deutschland. 2. BIH Charité Clinician Scientist Program, Berlin Institute of Health (BIH), Berlin, Deutschland. 3. Chirurgische Klinik, Campus Charité Mitte und Campus Virchow-Klinikum, Charité - Universitätsmedizin Berlin, Augustenburger Platz 1, 13353, Berlin, Deutschland. nathanael.raschzok@charite.de. 4. BIH Charité Clinician Scientist Program, Berlin Institute of Health (BIH), Berlin, Deutschland. nathanael.raschzok@charite.de.
Abstract
BACKGROUND: Liver transplantation is the only curative treatment option for patients with end-stage liver disease; however, the 40% decline of available organ donors in recent years in Germany necessitates the optimization of available resources and possibly extending the criteria to older donors. MATERIAL AND METHODS: All 2652 livers made available to the Charité Universitätsmedizin Berlin from 2010 to 2016 were retrospectively analyzed and the clinical outcome of 526 liver transplantations during this time frame were evaluated. RESULTS: The median age of donors of transplanted organs increased from 49.3 years in 2010 to 57.3 years in 2016 (p = 0.02). Organs from donors ≥65 years were more frequently discarded than organs from younger donors (n = 344, 18.4% vs. n = 220, 28.1%; p = 0.005). Moreover, the older donors had higher rates of diabetes mellitus and hepatic steatosis. Organs from older donors had a higher donor risk index (2.8 vs. 2.2; p < 0.001) and were transplanted more often in patients with preserved liver function and hepatocellular carcinoma and liver cirrhosis (n = 121, 74.7% of indications). The 3‑year survival after liver transplantation from donors ≥65 and ≥80 years old was not significantly reduced in comparison to younger donors; however, there was an increased retransplantation rate (28.6%; p = 0.005) after transplantation of organs from donors ≥80 years old. CONCLUSION: Despite conservative organ acceptance there were higher rates of retransplantation after transplantation from very old donors. In the light of an increasing scarcity of suitable organs this mandates caution and highlights the need for adequate assessment instruments for marginal donor organs before transplantation.
BACKGROUND: Liver transplantation is the only curative treatment option for patients with end-stage liver disease; however, the 40% decline of available organ donors in recent years in Germany necessitates the optimization of available resources and possibly extending the criteria to older donors. MATERIAL AND METHODS: All 2652 livers made available to the Charité Universitätsmedizin Berlin from 2010 to 2016 were retrospectively analyzed and the clinical outcome of 526 liver transplantations during this time frame were evaluated. RESULTS: The median age of donors of transplanted organs increased from 49.3 years in 2010 to 57.3 years in 2016 (p = 0.02). Organs from donors ≥65 years were more frequently discarded than organs from younger donors (n = 344, 18.4% vs. n = 220, 28.1%; p = 0.005). Moreover, the older donors had higher rates of diabetes mellitus and hepatic steatosis. Organs from older donors had a higher donor risk index (2.8 vs. 2.2; p < 0.001) and were transplanted more often in patients with preserved liver function and hepatocellular carcinoma and liver cirrhosis (n = 121, 74.7% of indications). The 3‑year survival after liver transplantation from donors ≥65 and ≥80 years old was not significantly reduced in comparison to younger donors; however, there was an increased retransplantation rate (28.6%; p = 0.005) after transplantation of organs from donors ≥80 years old. CONCLUSION: Despite conservative organ acceptance there were higher rates of retransplantation after transplantation from very old donors. In the light of an increasing scarcity of suitable organs this mandates caution and highlights the need for adequate assessment instruments for marginal donor organs before transplantation.
Entities:
Keywords:
Aged, 80 and over; Donor selection; Liver transplantation; Population dynamics; Resource allocation
Authors: Austin L Spitzer; Oliver B Lao; André A S Dick; Ramasamy Bakthavatsalam; Jeffrey B Halldorson; Matthew M Yeh; Melissa P Upton; Jorge D Reyes; James D Perkins Journal: Liver Transpl Date: 2010-07 Impact factor: 5.799
Authors: Esther L de Graaf; James Kench; Pamela Dilworth; Nicholas A Shackel; Simone I Strasser; David Joseph; Henry Pleass; Michael Crawford; Geoff W McCaughan; Deborah J Verran Journal: J Gastroenterol Hepatol Date: 2012-03 Impact factor: 4.029
Authors: Philipp Dutkowski; Andrea Schlegel; Ksenija Slankamenac; Christian E Oberkofler; Rene Adam; Andrew K Burroughs; Eric Schadde; Beat Müllhaupt; Pierre-Alain Clavien Journal: Ann Surg Date: 2012-11 Impact factor: 12.969
Authors: Martin K Angele; Markus Rentsch; Wolfgang H Hartl; Benedikt Wittmann; Christian Graeb; Karl Walter Jauch; Florian Loehe Journal: Am J Surg Date: 2008-02 Impact factor: 2.565
Authors: S Feng; N P Goodrich; J L Bragg-Gresham; D M Dykstra; J D Punch; M A DebRoy; S M Greenstein; R M Merion Journal: Am J Transplant Date: 2006-04 Impact factor: 8.086
Authors: Gerd R Silberhumer; Axel Rahmel; Vincent Karam; Mithat Gonen; Georg Gyoeri; Barbara Kern; Rene Adam; Ferdinand Muehlbacher; Xavier Rogiers; Andrew K Burroughs; Gabriela A Berlakovich Journal: Transpl Int Date: 2013-08-10 Impact factor: 3.782
Authors: Vladimir J Lozanovski; Larissa T B Kerr; Elias Khajeh; Omid Ghamarnejad; Jan Pfeiffenberger; Katrin Hoffmann; De-Hua Chang; Markus Mieth; Thomas Longerich; Oliver Strobel; Karl Heinz Weiss; Markus W Büchler; Arianeb Mehrabi Journal: J Clin Med Date: 2019-10-15 Impact factor: 4.241
Authors: Simon Moosburner; Leke Wiering; Safak Gül-Klein; Paul Ritschl; Tomasz Dziodzio; Nathanael Raschzok; Christian Witzel; Alexander Gratopp; Stephan Henning; Philip Bufler; Moritz Schmelzle; Georg Lurje; Wenzel Schöning; Johann Pratschke; Brigitta Globke; Robert Öllinger Journal: J Clin Med Date: 2022-02-09 Impact factor: 4.241
Authors: Simon Moosburner; Igor M Sauer; Frank Förster; Thomas Winklmann; Joseph Maria George Vernon Gassner; Paul V Ritschl; Robert Öllinger; Johann Pratschke; Nathanael Raschzok Journal: Hepatol Commun Date: 2020-12-05